MedPath

Risk Prediction and Its Intelligent Assessment for Cognitive Impairment Among Community-dwelling Older Adults

Completed
Conditions
Predictive Model
Cohort
Cognitive Impairment
Aging
Registration Number
NCT05385874
Lead Sponsor
Peking University Sixth Hospital
Brief Summary

Cognitive impairment is one of the core early signs of dementia, and it is also a key stage for community-based dementia prevention. Accurate and convenient prediction of cognitive impairment can help the community to identify and manage the high-risk population of dementia. Previous studies had developed several dementia predicting models, but such models may be not suitable for cognitive impairment prediction. Based on the national representative follow-up data of Chinese Longitudinal Healthy Longevity Survey (CLHLS), this project aims to develop and validate a brief cognitive impairment prediction algorithm among the community-dwelling elderly, using machine learning methods (such as Logistic regression, Naïve Bayes model, Extreme Gradient Boosting Tree and so on). Finally, based on the constructed model, an easy-to-use online intelligent assessment tool for predicting cognitive impairment risk will be developed. The general practitioners, social workers and the elderly would be invited to use the tool and we will revise the tool according to their suggestions and comments. This project is expected to provide scientific basis and technical support for community-based dementia prevention, and will also be useful for the elderly to easily understand their cognitive health.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
13228
Inclusion Criteria
  1. Aged 65 or over at baseline;
  2. With normal cognitive function at baseline (score ≥ 18 on the Chinese version of Mini-Mental State Examination, MMSE);
  3. Completed MMSE assessment three years later;
  4. Provided informed consent voluntarily.
Exclusion Criteria
  1. Aged <65;
  2. had a history of dementia or MMSE score < 18 at baseline;
  3. lost to follow-up or without cognitive function assessment three years later;
  4. Refused to participate the survey.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
AUCan average of 3 years after baseline assessement

the AUC of the prediciton model based on the test data

Secondary Outcome Measures
NameTimeMethod
sensitivityan average of 3 years after baseline assessement

the sensitivity of the prediciton model based on the test data

specificityan average of 3 years after baseline assessement

the specificity of the prediciton model based on the test data

negative predictive valuean average of 3 years after baseline assessement

the negative predictive value of the prediciton model based on the test data

positive predictive valuean average of 3 years after baseline assessement

the positive predictive value of the prediciton model based on the test data

Trial Locations

Locations (1)

Peking University Six Hospital

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath